- Filed
- Mar 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 28, 2026 | 149.89M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 117.14M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 114.55M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$138.51M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$20.44M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $88.88M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $125.99M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $61.01M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$131.99M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | −$193.43M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $140.39M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $282.98M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $197.33M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $580.52M |
| Current Assets | FY 2025 · Dec 31, 2025 | $206.71M |
| Current Assets | FY 2025 · Dec 31, 2024 | $341.58M |
| Total Assets | FY 2025 · Dec 31, 2025 | $258.34M |
| Total Assets | FY 2025 · Dec 31, 2024 | $448.53M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $1.43 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | $0.25 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $1.43 |
| Eps Basic | FY 2025 · Dec 31, 2024 | $0.25 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $100.6M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $125.48M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $108.89M |
| Rd Expense restated | FY 2025 · Dec 31, 2024 | $91.83M |
| Net Income | FY 2025 · Dec 31, 2025 | $168.02M |
| Net Income | FY 2025 · Dec 31, 2024 | $28.51M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$181.13M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | −$199.65M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $13.81M |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2024 | $8.73M |